Latest Articles

Publication Date
LGL: Paula S. Cousins Ovarian and Endometrial Cancer Foundation - yourerie.com

LGL: Paula S. Cousins Ovarian and Endometrial Cancer Foundation yourerie.com

Published: June 4, 2025, 9:50 p.m.
Study highlights the lasting toll of colorectal cancer on women's sexual health - News-Medical

Study highlights the lasting toll of colorectal cancer on women's sexual health News-Medical

Published: June 4, 2025, 6:16 p.m.
Colorectal cancer leaves lasting toll on women’s sexual health - EurekAlert!

Colorectal cancer leaves lasting toll on women’s sexual health EurekAlert!

Published: June 4, 2025, 4:42 p.m.
Colorectal Cancers Impact on Womens Sexual Health - Mirage News

Colorectal Cancers Impact on Womens Sexual Health Mirage News

Published: June 4, 2025, 3:32 p.m.
Women Survivors of Colorectal Cancer Face Long-Term Sexual Health Challenges - Technology Networks

Women Survivors of Colorectal Cancer Face Long-Term Sexual Health Challenges Technology Networks

Published: June 4, 2025, 3:30 p.m.
Colorectal cancer leaves lasting toll on women’s sexual health - UBC News

Colorectal cancer leaves lasting toll on women’s sexual health UBC News

Published: June 4, 2025, 2:55 p.m.
Paula S. Cousins Ovarian & Endometrial Cancer Foundation, Inc. is this week’s winner of Loving Giving Local - yourerie.com

Paula S. Cousins Ovarian & Endometrial Cancer Foundation, Inc. is this week’s winner of Loving Giving Local yourerie.com

Published: June 4, 2025, 2:22 p.m.
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com Canada

Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com Canada

Published: June 3, 2025, 8:43 a.m.
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com

Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com

Published: June 3, 2025, 8:41 a.m.
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer - Insider Monkey

Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer Insider Monkey

Published: June 3, 2025, 5 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!